BROOKE WATSON: Open Payments
NPI 1114402153 · SUMMERVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,992 in 134 payments from 21 companies in 2025. Trend: 2023 $2,133 · 2024 $1,757 · 2025 $1,992
Food & beverage: $1,992
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $444 |
| Celltrion USA Inc. | 25 | $235 |
| Gilead Sciences, Inc. | 10 | $206 |
| Janssen Biotech, Inc. | 14 | $170 |
| GENZYME CORPORATION | 4 | $102 |
| Intercept Pharmaceuticals, Inc. | 5 | $97 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $95 |
| Novo Nordisk Inc | 3 | $83 |
| Regeneron Healthcare Solutions, Inc. | 4 | $75 |
| PFIZER INC. | 4 | $74 |
Products named: RINVOQ, VEGZELMA, DUPIXENT, TREMFYA, OCALIVA, Wegovy, ENTYVIO, SKYRIZI.
Industry payments across SC — which companies pay providers there.
